Amedeo Amedei (01.04.1971), on 1996 he graduated with full marks and honors in Biology at Florence University. He has started his career with a scholarship (1997-99) studying the role of T cells in various diseases (GVHD, atopic dermatitis, kidney rejection). From 2000 to 2002 he has examined the mechanisms that regulate the gastric chronic inflammatory process; in detail, the role of specific immune response versus Helicobacter pylori in gastric diseases (gastritis, ulcer, maltoma, gastric cancer). On 2003 began his doctor's degree in "Clinical and Sperimental Medicine" and collaborated on the regional project " Stem cells and immune-therapy of cancer". In March 2005 becomes scientific researcher, and since November 2015 he has been working as an at Department of Experimental and Clinical Medicine (University of Florence). In the last years, he has focused his scientific interests on the cancer and in detail, the anti-cancer immune response and the role of cancer microenvironment. Recently, he became a member of the team of researchers involved in the project world "Halifax Project". The project involves about 300 international researchers, divided into two working groups. A task force is focused on advanced cancer treatments. The second task force is focused on the carcinogenic potential of exposure to low doses of mixtures of chemicals in the environment. The data have produced 11 papers for the important cancer journal “Carcinogenesis” (I.F. = 5.334) and 12 articles for the prestigious scientific journal “Seminars in Cancer Biology” (I. F= 9.330). The Dr. Amedei is coauthor of all 23 manuscripts. The his scientific production is composed of 117 peer reviewed articles (2,919 Citations and Impact Point: 600.19), 6 book chapters and one patent (WO/2007/039451). At present, he is serving as an editorial board member of 34 reputed journals and reviewer of 41 international journals. To date the Dr. Amedei has been granted various grants as principal investigator. For more details about the scientific production http://www.researchgate.net/profile/Amedeo_Amedei.
Mohamed Hamdy Doweidar, University of Zaragoza, Spain
Mohamed Hamdy Doweidar is a Full Associate Professor at the Mechanical Engineering Department, University of Zaragoza, Spain. Besides, he is a Member of the Group of Structural Mechanics and Materials Modeling (GEMM), the Biomedical Research Networking Center in Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), the Aragón Institute of Engineering Research (I3A), and the European Society of Biomechanics (ESB). Dr. Doweidar has participated in many national and international investigation projects. He has authored and co-authored many books and numerous articles in international journals. His investigation interests include Computational Biomechanics, Cell Simulation, Finite Element Method, Natural Element Method and Computational Fluid Dynamics.
Computational Biomechanics, Cell Simulation, Finite Element Method, Natural Element Method and Computational Fluid Dynamics.
Ming-Zhi Zhang, Nanjing Agricultural University, China
Dr. Ming-Zhi Zhang, is currently a lecturer of chemistry and pesticide science in the College of Sciences, Nanjing Agricultural University (NAU), P.R. China. He received his BS degree in applied chemistry from Central China Normal University (CCNU) in 2008, and obtained his Ph.D. degree majored in pesticide science from Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, CCNU in 2013, focused on the research of design, synthesis and antifungal activity of natural products, which were cooperation projects with agrichemical giant Syngenta. After the doctoral study, Dr. Zhang furthered his research as a visiting scholar at GlaxoSmithKline RTP site, NC, USA, involved in small molecule drug discovery research focused on finding therapeutic agents to treat human rhinovirus (HRV) and other viruses. In 2015, he started a faculty career in NAU, focusing currently on natural products based lead discovery for fungicide and mechanism of action.
1. Natural products based lead discovery for fungicide (Synthesis, QSAR and biological evaluation) and mechanism of action.
2. Design, synthesis and lead optimization of antiviral agents.
Xiaohong Li, Southwest Jiaotong University, China
I am a professor of biomaterials at School of Materials Science and Engineering, Southwest Jiaotong University. My current research interests are biomaterials design, controlled drug release for cancer treatment and tissue regeneration. I received my B.A. in 1991 from Fudan University, M.Sc. in Polymer Chemistry and Physics in 1994 from Chengdu Institute of Organic Chemistry, Chinese Academy of Sciences, and Ph.D. in Chemistry in 1999 from Institute of Chemistry, Chinese Academy of Sciences. I was a postdoctoral fellow in College of Pharmacy, Ohio State University (2000-2002) and Department of Biomedical Engineering, Johns Hopkins University (2002-2004).
I have over 100 publications to my credit that include research papers and reviews. I am a member of Controlled Release Society (CRS), Tissue Engineering and Regenerative Medicine International Society (TERMIS), and Chinese Committee of Biomaterials (CCBM).
Now I serve as an editorial board members of international journals, such as The Open Natural Product Journal, Journal of Biochemistry and Molecular Biology Research, and Hepatoma Research.
Majid Ghayour-Mobarhan, Mashhad University of Medical Sciences (MUMS), Iran (Islamic Republic of)
Reza Pilehchian Lanroudi, Razi vaccine and Serum Research Institute, Iran (Islamic Republic of)
Dr. Reza Pilehchian Langroudi has received his PhD in National Institute of Genetics and Biotechnology (NIGEB) during the period of 4 years.Currently, he is working as Associate professor, senior researcher and Head of anaerobic vaccine department in Razi vaccine and Serum Research Institute and is working about 28 years in this institute. He has developed about six new vaccine for veterinary use in Iran and now he is working on Clostridial nano toxoid vaccine in Iran. His publication in Vaccine Journal in 2013 indicated that for the 1st time in the world, he has developed a new epsilon-beta fusion protein as immunogenic construct for immunization of domestic animals. He is serving as an editorial member of several reputed journals like as Archive of Rzai institute. He has authored more than 95 research articles and 9 books. He is a member of Iranian Biology, as well as Iranian Biotechnology society.
Molecular genetics, genetic engineering, cell and molecular Biology, vaccine.
Farzad Khademi, Mashhad University of Medical Sciences (MUMS), Iran (Islamic Republic of)
Helicobacter pylori, Mycobacterium tuberculosis and nontuberculous mycobacteria (NTM) (molecular epidemiology, antibiotic resistance, development of new vaccines).
Yen-Hui Lin, Central Taiwan University of Science and Technology, Taiwan
My primary study included the design and implementation of fixed-biofilm process for simultaneous removal of multiple contaminants in industrial wastewater, and development of the kinetic model to simulate the performance of biofilm process. Recent research has emphasized on azo-dye decolorization in a biological activated carbon process and chromium(VI) bioreduction by E. coli 33456 on chitosan beads. Simultaneous removal of phenol and chromium(VI) in an anaerobic fixed-biofilm process was also investigated. A novel moving-fixed bed biofilm reactor was developed to remove organic carbon and ammonium-nitrogen simultaneously. The valuable biohydrogen production from food processing wastewater using newly developed high-rate anaerobic wastewater treatment technologies was conducted. Moreover, Conversion of CO2 into CH4 by methane-producing bacterium under a pressurized condition was evaluated in the batch tests. Bioleaching technologies have also applied to recover the heavy metals from industrial waste sludge by indigenous Acidithiobacilli. Current funded research projects include removal of textile wastewater by using fly ash-chitosan composite supporting media in fluidized-bed bioreactor and the removal of organic carbon and ammonium-nitrogen in leachate using fly ash-waste sludge-clay as a composite supporting medium in a oxic/anoxic biofilm reactor.
Tetiana Butova, University of Kharkiv municipal ambulatory, Ukraine
Mahmoud Rezk Ali AbouLaila, University of Sadat City, Egypt
Mahmoud Rezk AbouLaila is an Associate Professor of Parasitology, Faculty of Veterinary Medicine, University of Sadat City, Egypt. He was a visiting researcher at Obihiro University of Agriculture and Veterinary Medicine, Japan. He was JSPS fellow at Obihiro University of Agriculture and Veterinary Medicine, Japan. He Obtained his Ph.D. from Obihiro University of Agriculture and Veterinary Medicine, Japan. During his Ph.D. and the fellowships, he focused on developing diagnostic and drug therapy for Babesia and Theileria Parasites. He also identified the drug target enzymes inBabesia Parasites for some drugs. He identified some proteins as vaccine candidates for Babesia control. He conducted molecular and serological epidemiological surveys for these parasites worldwide.
Parasites, Molecular and Serological Diagnosis, Treatment, Drug Targets, Vaccines.
Mohamed A. Shaker, Helwan University Cairo, Egypt
Biodegradable Polymer synthesis, structure, morphology, crystalline and amorphous polymers, polymer networks, mechanical properties and processing for controlled drug delivery. Creating new bioerodible-materials, polymeric matrix systems, polymers containing pendant drug substituents which will ultimately be absorbed by the body. Creating new approaches for delivering drugs across complex barriers in the body such as the blood-brain barrier, as they relate to the design of effective targeting formulations and emerging pharmaceutical technologies (e.g. nano/micro-engineering). Developing controlled release systems that can be osmotically triggered to increase release rates. Studying applications of these systems including the development of effective long-term delivery systems for cytokines. Investigating the mechanism of release from polymeric delivery systems with concomitant microstructural analysis and mathematical modeling. Strategies for using liposomes to target drugs to specific cells or organs and the new methods for producing liposomes.Technology of microencapsulation including coacervation, phase separation, polymerization, spray-drying, electrostatic methods, and air suspension approaches. Development of self-regulated delivery systems to the controlled release of drugs; approaches for achieving zero release kinetics.
Development and validation of chromatographic techniques (HPLC, LC-MS/MS) in biological fluids: application to pharmacokinetic studies, bioavailability/bioequivalence studies and therapeutic drug monitoring, Analysis of drugs and endogenous compounds using ELISA: clinical applications, Population pharmacokinetic studies of drugs.
Darshan Maganlal Rudakiya, Sardar Patel University, India
Darshan Rudakiya is currently working as lecturer and Ph.D. Scholar (thesis submitted) at N. V. Patel College of Pure & Applied Sciences (Sardar Patel University), Gujarat, India. He completed his Master and Bachelor degree from Sardar Patel University. He is an author of 9 international/national articles and 1 book chapter. He actively participates in more than 4 international societies. He has been assigned as a reviewer (Journal of Environmental chemical Engineering (Elsevier); World journal of engineering (Emerald Group); African J of Microbiological Research (Academic Publisher). Currently, he is an editorial member of IL J of biotechnology and biomedical research.
Research Interest: Biological Science, Biotechnology, Molecular Biology
Mitra Mobin, Centro Universitário UNINOVAFAPI, Brazil
Full Degree in Biology by the Federal University of Piauí, Master in Biology of Fungi by the Federal University of Pernambuco, Specialization in Prevention and Control of Hospital Infections by the Faculty of Health Humanities and Technology of Piauí-NOVAFAPI and PhD in Sciences, by the Control Coordination Of Diseases - Secretary of State for Health - São Paulo. She is currently Full Professor1B of UNINOVAFAPI University Center in the areas of Dentistry, Biomedicine, Nutrition and Radiology. Has experience in the areas of Biosafety, Microbiology with an emphasis on Mycology. Currently, he guides research projects and graduation courses in different health disciplines. He is a reviewer in international journals (Journal of Mycologie Médicale, African Journal of Microbiology and Research, International Journal of Nutrition and Metabolism). Leader of the research group: Nucleus of Study and Research in Microbiology and Biosafety (NEPEMBIO) at UNINOVAFAPI; Member of the group Diseases caused by fungi: Aspects related to agent, environment and host of the Adolfo Lutz Institute - São Paulo.
Research Interest: Mycology, Microbiology, Natural Products, Public Health Biosafety
Liu Yang, University of Hoehenheim, China
Research Interest: Mycotoxin formation, Prevention and Control of Mycotoxins, Detoxification of mycotoxins , Survey of mycotoxins in food and feed, Toxicology of mycotoxins.
Yusuf TUTAR, University of Health Sciences, Turkey
Dr. Yusuf TUTAR obtained his M.Sc. and Ph.D. at Oregon State University and Texas Tech University respectively. He pursued his postdoctoral study at National Institutes of Health (NIH/NIDDK), USA. His research focuses on Biochemistry, Biophysics, Genetics, and Molecular Biology with specialization in the fields of protein structure-function, protein folding, prion, microrna, pseudogenes, molecular cancer, proteomics, genomics, protein expression and characterization by spectroscopic and calorimetric methods.
· Molecular Cancer Research and epigenetic (RT-PCR and Microarray).
· MicroRNA, pseudogenes, and transfection.
· Prion, translation termination in eukaryotes, and transcription initiation in prokaryotes.
· Investigating structure-function relationship of biological macromolecules with biochemical, biophysical, genetics and molecular biological methods.
· Recombinant DNA technology, molecular sub-cloning, transformation and protein expression.
· Drug design, docking, molecular dynamics.
· Nanoparticles for drug targeting.
Protein purification (Heat shock, Catabolite repressor and S100P proteins) and characterisation (Spectroscopy: Fluorescence, Luminescence, CD, FTIR; Calorimetry: NanoDSC and ITC; Chromatography: HPLC and FPLC; Other techniques: MALDI-TOF, GC, SPR)